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Abstract 
Objectives: The authors have conducted a systematic review of oral manifestations of HIV from studies conducted 
in Asia to establish the characteristics and prevalence of individual oral manifestations in Asia, and to assess the 
direction of future research studies on oral manifestations of HIV in Asia. 
Material and Methods: The electronic retrieval systems and databases searched for relevant articles were PubMed 
[MEDLINE], EBSCO, and EMBASE. The search was for limited articles published in English or with an English 
abstract and articles published during the period January 1995 to August 2014. The authors reached a final overall 
sample of 39 studies that were conducted in Asia.
Results: The median population size among all studies was 312.7 patients. Oral candidiasis [OC] was the most 
common oral manifestation [37.7%] in studies conducted in Asia. The overall prevalence of oral hairy leukoplakia 
and melanotic hyperpigmentation was computed to be 10.1% and 22.8% respectively. Thailand and India are pri-
marily countries with maximum research on oral manifestations.
Conclusions: The research on oral manifestations of HIV in Asia has to upgrade to more interventional and thera-
peutic studies rather than the contemporary cross- sectional epidemiological descriptive studies. The authors have 
given suggestions and future directions for the implementation of clinical research of oral manifestations in HIV 
patients.
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Introduction
Human Immunodeficiency Virus [HIV] is a massive and 
byzantine challenge for the public health system. The 
spread of HIV infection in Asian countries is a major 
concern that is still showing a rising trend (1). Despite 
a 26% reduction in HIV infections since 2001, the pan-
demic still outpaces the response and half of the people 
[49%] in Asia pacific region are unable to access the 
anti-retroviral therapy. The overall national prevalen-
ce in Asian countries is low, a misleading true statistic, 
that tends to camouflage the real pandemic threat. The 
huge volume of Asian population ensures that even a 
low prevalence transmutes into a colossal HIV infected 
population in numbers. HIV infection is of portentous 
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significance as majority of the patients belong to eco-
nomically and reproductively active group within their 
communities which can have a devastating effect on the 
socio-economic status of nation.
Oral manifestations in HIV infection have been well 
documented as early markers of HIV infection and pro-
gression (2). Oral manifestations of HIV/AIDS [Acqui-
red immunodeficiency syndrome] are significant as they 
may affect the patients’ quality of life and can be used 
to assess the status of immunosuppression and determi-
ne the prognosis of the disease (3). Early diagnosis and 
appropriate treatment of oral lesions have great influen-
ce on patients’ general health and can reduce the mortali-
ty rate of the disease. Thus it becomes imperative for all 
health care workers to be equipped with the necessary 
knowledge and expertise to manage oral manifestations 
of HIV infection.
There are considerable regional variations in the oral 
manifestations of HIV infection, depending both on the 
populations studied and on the clinical heterogeneity 
(3). The oral manifestations in Asian countries as com-
pared to western countries and other developing nations 
in Africa and Latin Americas are relatively different (2). 
The constraint of resources in Asian countries hinders 
the possibility of providing an effective health care sys-
tem. Though many studies have been conducted on oral 
manifestations in HIV, the research in Asia is currently 
at a pivotal juncture as the existing research is getting 
repetitive. Currently, Asian studies predominantly focus 
on prevalence of oral manifestations and assess their as-
sociation with parameters of HIV infection, sociodemo-
graphic data and deleterious habits. An oral lesion index 
is required that can assist health care workers to identify 
the oral manifestations and thus evaluate the predictabi-
lity of the immune status in HIV patients especially in a 
resource constrained settings. The authors have hereby 
conducted a systematic review of oral manifestations of 
studies conducted in Asia to establish the characteristics 
and prevalence of individual oral manifestations in Asia, 
and to assess the direction of future research studies on 
oral manifestations of HIV in Asia. The author’s primary 
aim is to provide a computed prevalence of the oral ma-
nifestations of HIV/AIDS in Asia that would help in the 
possibility of formulation of oral lesion index in the fo-
reseeable future.
Material and Methods 
The systematic review was based on the ongoing research 
on oral manifestations of HIV/AIDS. The geographical 
region of Asia was considered primarily as the maximum 
number of HIV patients is currently present in Asia. The 
PubMed interface of MEDLINE was interrogated by 
MeSH and free-text words. A comprehensive literature 
search was executed till August 2014. The MeSH was 
‘‘oral, lesions’’, “oral manifestations”, HIV”, “AIDS”. 
The electronic retrieval systems and databases searched 
for relevant articles were PubMed [MEDLINE], EBS-
CO, and EMBASE. The search was for limited articles 
published in English or with an English abstract and arti-
cles published during the period January 1995 to August 
2014. Each country located within Asia [countries were 
included according to United Nations website code 142] 
was individually typed in concurrence with the above 
mentioned Mesh words. Only oral epidemiological stu-
dies related to oral manifestations of HIV were included. 
All the studies that had followed presumptive criteria of 
EEC clearinghouse classification [1993] were included. 
Articles were manually retrieved from National Medical 
Library, New Delhi. Relevant cross references of the ar-
ticles were also retrieved manually or electronically.
The shortlisted studies were screened and independently 
categorized by all the authors. Any disagreement bet-
ween the authors regarding article and data extraction 
was sorted. In reading the articles, the reference lists 
were checked to identify any other articles that may 
have been relevant to the research question or provided 
additional information. Individual prevalence rates were 
observed and were computed manually wherever it was 
required. The exclusion criteria to ensure uniformity of 
the studies were:
1. Studies on oral manifestations done outside Asia were 
excluded. Russia was excluded due to geographical 
overlap with Europe.
2. Exclusive HIV paediatric studies were excluded.
3. Interventional studies for oral manifestations in HIV 
patients were not included.
4. Individual case reports were excluded.
The authors reached a final overall sample of 39 studies 
(4-42) that were conducted in Asia after applying the ex-
clusion criteria (Methodology described in Table 1). 
Results
Tabulation of the research studies (4-42) conducted on 
oral manifestations in Asia was done (Table 2, Table 
2(Cont).). Majority of the studies [25/39; 64.1%] have 
been conducted in India and Thailand. No research stu-
dies on oral manifestations of Asia were documented in 
37 countries. Population of sample study ranged from 
32 patients (8) to 3729 patients (38). The median po-
pulation size among all studies was 312.7 patients. The 
primary mode of transmission of HIV in studies con-
ducted in Asia is predominantly heterosexual route [ove-
rall 76.5%]. Males were more affected with HIV than 
females in almost all the studies except in a recent stu-
dy (41) where all the 292 patients were HIV infected 
pregnant women. Anti-retro viral therapy [ART]’s usage 
was documented in twenty one studies [21/39; 53.8%]. 
ART was observed in these studies with varying percen-
tages and the combined prevalence of patients on ART in 
Asian studies was observed to be only 35.7%.
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Literature search strategy
Key word- “HIV”, “AIDS”, “Oral Manifestations”, “Asia”, “Names of all the Asian 
countries individually such as china, Pakistan, Singapore, Jordan, etc”
Asia 45
China 09
Cambodia 02
Georgia  03
India 40
Iran 09
Israel 04
Japan 07
Malaysia 02
Nepal 01
Thailand 21
Taiwan 03
Singapore 03
Vietnam 02
All the other 
Asian 
countries
Zero
Total 155
Application of the exclusion criteria and usage of cross referencing and manual search with 
relevant articles at title stage
50
Duplicate articles removed 45
Relevant articles at abstract stage 44
Relevant articles at full stage 39
Table 1. Depicts the key words and their combinations used in the literature search for oral manifestations in HIV.
-Oral candidiasis
Oral candidiasis [OC] was the most common oral ma-
nifestation [37.7%] in studies conducted in Asia. The 
exact prevalence was difficult to ascertain in review as 
some researchers had listed only the subtypes of oral 
candidiasis. The range of OC varies broadly from a high 
prevalence of 81% (4) to 11% (26) (Fig. 1). Pseudomem-
branous candidiasis [average prevalence- 20.4%; range 
1.9%-64%] and erythematous candidiasis [average pre-
valence- 20.9%; range 2.5%-44.5%] were equally obser-
ved where the subtype was clearly mentioned in the stu-
dy. Hyperplastic candidiasis was reported infrequently 
with a low prevalence of 1% from studies conducted by 
Ranganathan et al. (9,16).  Angular cheilitis was obser-
ved in Asia with an overall prevalence of 8.1%, though 
Nittayananta et al. (13) and Annapurna et al. (34) had 
observed higher prevalence rates of 18.3% and 18% res-
pectively.
-Oral Hairy Leukoplakia 
Oral Hairy Leukoplakia [OHL], caused by Epstein Barr 
virus [EBV], was the most common oral manifestation 
in only one study conducted by Khongkunthian et al. 
(11) in Thailand. The combined prevalence of all the 
studies conducted revealed a value of 10.1% with a ran-
ge of 0.2% to 45.5% (Fig. 2). Only four studies did not 
document OHL (33,35,39,42). The prevalence of OHL 
was higher in few studies varying from 26.3% by Nitta-
yananta et al. (13) in 2001 to 45.5% by Bendick et al. 
(14).
-Melanotic hyperpigmentation
The overall prevalence of melanotic hyperpigmentation 
was computed to be 22.8 % and was observed in twen-
ty studies. Melanotic hyperpigmentation was the most 
common HIV-associated oral manifestation in studies 
conducted by Sud et al. (24) in 2009, Davoodi et al. (25) 
in 2010 and Nittayananta et al. (27) in Thailand. The pre-
valence of melanotic hyperpigmentation has been higher 
in studies reported by Sharma et al. (20) [34.6%] in 2006 
and Nittayananta et al. (27) [38.2%] in 2010. However, 
a low prevalence of 1.4% in Hong Kong documented by 
Tsang and Samaranayake (8) can be attributed to lack of 
anti-retroviral therapy in their study sample.
-Oral malignancies
Oral cancer was observed only in two studies with pre-
valence rates of 4% and 2% (4,34). Anil and Challacom-
be (4) revealed a high incidence of squamous cell car-
cinoma in the studied population. Recently, Khatibi et 
al. (30) and Perera et al. (37) had reported a prevalence 
of 1.9% and 1% of oral Kaposi’s sarcoma respectively. 
The prevalence of Non-Hodgkin’s Lymphoma [NHL] in 
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Authors
(year)
Reference 
number 
Country
(Region) 
Populatio
n size 
Heterosexual 
(%) 
OC
(%) 
EC
(%) 
PC
(%) 
OHL 
(%) 
AC
(%) 
Hyperpigmentation 
(%) 
Aphthou
s ulcers 
(%) 
Herpes 
infection 
(%) 
NU
G
(%) 
NUP 
(%) 
Periodontitis 
(%) 
Oral 
cancer
(%) 
ART
%
Anil and 
Challacombe  
(1997) 
(4) India 96 79 81 21 64 7 13 - 6 - - - 23 4 - 
Nittayananta 
et al.  (1997) 
(5) Thailand 41 100 76 - - 7 - - - - - - - - - 
Nittayananta  
et al. (1997) 
(6) Thailand 124 - 66 25 53 13 - - - - - - - - - 
Jing et al.
(1999) 
(7) Malaysia 145 80.7 35.9 - - 2.8 - - - - - - - - 22.7 
Tsang and 
samranayake 
(1999) 
(8) China 
(Hong 
Kong) 
32 40.6 - 6.9 5.5 11 - 1.4 27.4 4.1 – 
HSV 
2.7 1.4 - - - 
Ranganathan 
et al. (2000) 
(9) India 300 89.3 56 14 32.7 3 7.7 23 - - - - - - - 
Shimizu et al.
(2000) 
(10) Japan 110 0 15 - - 1.8 - - - - - - - - 28.3 
Khongkunthi
an  et al.
(2001) 
(11) Thailand 87 96.6 - 6.9 10.3 11.5 6.9 - - 1-HSV - - - - 18 
Lim  et al.
(2001) 
(12) Singapore 81 - 35 - - 5 - - 5 - - - 16 - - 
Nittayananta  
et al. (2001) 
(13) Thailand 364 66.9 39.6 - - 26.3 18.3 - - - - - - - - 
Bendick et al 
(2002) 
(14) Cambodia 101 91 - 22.8 52.5 45.5 12.9 - - 4 - HZ, 
7.9 – 
HSV 
27.7 - - - 0 
Kerdpon et
al.  (2004) 
(15) Thailand 237 88.9 40 21.5 28.5 29.5 3.5 - 5 - 1.5 0.5 14.5 - 31.2 
Ranganathan 
et al. (2004) 
(16) India 1000 95 23.8 16.1 3.1 3.3 7.9 26.3 - 3.3 - HZ, 
0.9 – 
HSV 
- - 33.2 - 10.7 
Shobhana et
al. (2004) 
(17) India 410 90.4 36 - - 3 1 3 3 5-HSV - - - - - 
Tzung  et al.  
(2004) 
(18) Taiwan 64 55.3 71.1 - - 8 - - - - - - - - - 
               
Jensen et al.
(2005) 
(19) Vietnam 170 - 37.5 - - 16.1 - - - - - - - - - 
Sharma et al.
(2006) 
(20) India 101 96 - 44.5 11.8 15.8 11.8 34.6 4.7 1.9 – HZ 0.9 - - - 16 
Umadevi et
al. (2007) 
(21) India 100 - 16 5 11 1 3 29 1 - - - - - 50 
Kakabadze et
al. (2008) 
(22) Georgia 732 - 64 - - 8 - - - 7 - HSV, 
5 – HPV 
- - - - - 
Sharma et al.
(2009) 
(23) India 200 98 - 44 10.5 18.5 9 33.5 5 1 - HZ, 2 
– HSV 
9 7 - - 40.5 
Sud et al. 
(2009) 
(24) India 150 96 - - - 2.6 - 29.3 - - - - - - 39.3 
Davoodi et al.
(2010) 
(25) Iran 100 54 - 36 7 4 17 42 - - - - 44 - 15 
Sen et al.
(2010) 
(26) India 321 88.3 11 - - 2.8 0.6 1.2 4 3.1-HSV - - 17.3 - 100 
Nittayananta  
et al. (2010) 
(27) Thailand 207 78.3 - 2.5 1.9 2.5 - 38.2 3.2 - - - 82 - 63.1 
Nittayananta  
et al. (2010) 
(28) Thailand 268 69.4 38.8 23.8 21.6 25.3 7.4 - - - - - - - 5.9 
Bodhade et
al. (2011) 
(29) India 399 85 39.3 30.6 12.3 11.5 4.3 19.5 2.5 0.3 - HZ, 
2 – HSV 
8.5 5.3 - - 0 
Khatibi et al. 
(2011) 
(30) Iran 200 13.4 22 - 16.5 3 - 5.5 - - 4 1.5 - - 68 
Gaurav S et
al. (2011) 
(31) India 103 98 44 38.8 8.7 17.5 5.8 35.9 4.9 1.9 – HZ 9.7 3.9 - - 40.8 
Sontakke et
al. (2011) 
(32) India 124 99 32 8 20 4 - 31 - - - - - - - 
               
Patil et al.
(2011) 
(33) India 96 - - 10.7 35.6 - 8.2 8.2 2.7 5.5-
HZ,1.4-
HSV 
- 8.2 - - 11.3 
Annapurna et
al. (2012) 
(34) India 50 96 36 - - 2 18 28 6 4 – HZ  - - 2 30 
Chopra and 
Arora (2012) 
(35) India 604 86.6 32.2 - - - - - 4.4 3.3-HSV  - - - - 
Table 2. Published studies conducted on oral manifestations in HIV/AIDS included in the review.
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Bendick et al 
(2002) 
(14) Cambodia 101 91 - 22.8 52.5 45.5 12.9 - - 4 - HZ, 
7.9 – 
HSV 
27.7 - - - 0 
Kerdpon et
al.  (2004) 
(15) Thailand 237 88.9 40 21.5 28.5 29.5 3.5 - 5 - 1.5 0.5 14.5 - 31.2 
Ranganathan 
et al. (2004) 
(16) India 1000 95 23.8 16.1 3.1 3.3 7.9 26.3 - 3.3 - HZ, 
0.9 – 
HSV 
- - 33.2 - 10.7 
Shobhana et
al. (2004) 
(17) India 410 90.4 36 - - 3 1 3 3 5-HSV - - - - - 
Tzung  et al.  
(2004) 
(18) Taiwan 64 55.3 71.1 - - 8 - - - - - - - - - 
               
Jensen et al.
(2005) 
(19) Vietnam 170 - 37.5 - - 16.1 - - - - - - - - - 
Sharma et al.
(2006) 
(20) India 101 96 - 44.5 11.8 15.8 11.8 34.6 4.7 1.9 – HZ 0.9 - - - 16 
Umadevi et
al. (2007) 
(21) India 100 - 16 5 11 1 3 29 1 - - - - - 50 
Kakabadze et
al. (2008) 
(22) Georgia 732 - 64 - - 8 - - - 7 - HSV, 
5 – HPV 
- - - - - 
Sharma et al.
(2009) 
(23) India 200 98 - 44 10.5 18.5 9 33.5 5 1 - HZ, 2 
– HSV 
9 7 - - 40.5 
Sud et al. 
(2009) 
(24) India 150 96 - - - 2.6 - 29.3 - - - - - - 39.3 
Davoodi et al.
(2010) 
(25) Iran 100 54 - 36 7 4 17 42 - - - - 44 - 15 
Sen et al.
(2010) 
(26) India 321 88.3 11 - - 2.8 0.6 1.2 4 3.1-HSV - - 17.3 - 100 
Nittayananta  
et al. (2010) 
(27) Thailand 207 78.3 - 2.5 1.9 2.5 - 38.2 3.2 - - - 82 - 63.1 
Nittayananta  
et al. (2010) 
(28) Thailand 268 69.4 38.8 23.8 21.6 25.3 7.4 - - - - - - - 5.9 
Bodhade et
al. (2011) 
(29) India 399 85 39.3 30.6 12.3 11.5 4.3 19.5 2.5 0.3 - HZ, 
2 – HSV 
8.5 5.3 - - 0 
Khatibi et al. 
(2011) 
(30) Iran 200 13.4 22 - 16.5 3 - 5.5 - - 4 1.5 - - 68 
Gaurav S et
al. (2011) 
(31) India 103 98 44 38.8 8.7 17.5 5.8 35.9 4.9 1.9 – HZ 9.7 3.9 - - 40.8 
Sontakke et
al. (2011) 
(32) India 124 99 32 8 20 4 - 31 - - - - - - - 
               
Patil et al.
(2011) 
(33) India 96 - - 10.7 35.6 - 8.2 8.2 2.7 5.5-
HZ,1.4-
HSV 
- 8.2 - - 11.3 
Annapurna et
al. (2012) 
(34) India 50 96 36 - - 2 18 28 6 4 – HZ  - - 2 30 
Chopra and 
Arora (2012) 
(35) India 604 86.6 32.2 - - - - - 4.4 3.3-HSV  - - - - 
Table 2. (Cont). Published studies conducted on oral manifestations in HIV/AIDS included in the review.
OC- oral candidiasis, EC-Erythematous candidiasis, PC-Pseudomembranous candidiasis, OHL-Oral hairy leukoplakia , AC-Angular cheilitis, 
HSV-Herpes simplex virus, HZ-Herpes zoster, HPV-Human papilloma virus infection, NUG-Necrotizing ulcerative gingivitis, NUP-Necrotiz-
ing ulcerative periodontitis, ART-Anti retroviral therapy.
Fig. 1. Scatter diagram showing oral candidiasis prevalence in the 
conducted studies on oral manifestations in HIV. Fig. 2. Scatter diagram showing oral hairy leukoplakia prevalence in 
conducted studies on oral manifestations in HIV.
Asian studies has been found to be very low as compa-
red to developed countries (15).NHL was however ob-
served with a prevalence of 4% in a study conducted by 
Nittayananta et al. (6) in 1997.
-HIV associated periodontal disease
HIV associated periodontal disease includes Necrotizing 
ulcerative gingivitis [NUG], necrotizing ulcerative pe-
riodontitis [NUP] and linear gingival erythema [LGE]. 
The average prevalence of NUG and NUP have been 
found to be 7.6% and 4.2% respectively. NUG has been 
found in a prevalence of 27.7% in Cambodia (14) and 
9% in India (23). The prevalence of NUP has typically 
remained low in studies from Asia with a prevalence of 
0.5% [Thailand] (15) 1.5% [Iran] (30), and 3.9% [India] 
(31). The prevalence of LGE has remained variable with 
Khatibi et al. (30) observing a high prevalence of 22% in 
their study from Iran, whereas Sontakke et al. (32) had 
documented a low prevalence of 2.4% in their study.
-HIV Salivary gland disease
The prevalence of parotid gland enlargement has typi-
cally remained low [around 1%] (15). HIV infection has 
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also been known to cause xerostomia and salivary gland 
hypofunction. Nittayananta et al. (27) had found a sig-
nificant reduction of both stimulated and unstimulated 
salivary flow in patients with HIV. Sharma et al. (20) 
had observed a prevalence of around 30% in their cross 
sectional study and Davoodi et al. (25) had documented 
20% prevalence of xerostomia.
-Ulcers
The computed prevalence of apthous stomatitis was ob-
served to be 4.1%. However, Tsang and Samaranayake 
(8) had observed a very high prevalence of 27.4% in 
their cohort of 32 HIV patients from Hong Kong. Ul-
ceration [Not otherwise specified (NOS)] has also been 
observed in a prevalence of around 3% (15). However, 
Nittayananta et al. (6) had documented 11% prevalence 
of ulceration [NOS] in their cohort from Thailand.
-Viral infections
Viral infections [other than EBV and HPV] afflicting the 
oral mucosa in HIV patients encompasses Herpes sim-
plex virus infections [HSV], Varicella zoster virus[VZV] 
and cytomegalo virus [CMV]. The prevalence of herpes 
simplex associated oral ulcers [HSV], Herpes zoster 
[VZV] and CMV associated salivary gland disease is 
extremely low in Asian countries. Herpes zoster preva-
lence in Indian studies ranged from 0.3% to 1.9% (29, 
31). A Cambodian study had observed a high prevalen-
ce of 7.9% HSV infection (14) whereas an Indian study 
(9) had observed a very low prevalence of 0.9% HSV 
infection.
-Miscellaneous oral manifestations 
No oral warts were observed or reported from studies 
in Asian countries (31). Histoplasmosis and penici-
lliosis caused by Penicillium marneffei were observed 
in studies conducted in Thailand and were found to be 
associated with severe immunosuppression (13,15,28). 
However, reports of penicilliosis were not documen-
ted in other Asian studies. Oral submucous fibrosis and 
homogenous leukoplakia were more frequently found 
in studies conducted in south India by Ranganathan et 
al. (16). Reports of exfoliative cheilitis were scarce in 
Asian studies (11). Bodhade et al. (29) had however 
observed nine cases of mollascum contagiosum in their 
study from India.
Discussion
The systematic review on oral manifestations in HIV re-
vealed a predominant heterosexual transmission mode 
[76.5%]. However in studies conducted by Tsang and 
Samaranayake (8) and Bakhshaee et al. (42) primary 
mode of transmission was homosexual route and intra-
venous drug users. Nittayananta et al. (28) in a study 
in 2010 had compared the oral manifestations with the 
route of transmission and had observed OC and OHL 
to be significantly associated with heterosexual route of 
transmission. Thailand and India are primarily countries 
with maximum research on oral manifestations. This 
could possibly be attributed to a larger HIV infected po-
pulation in these countries. The authors have summari-
zed the trends of oral manifestations of HIV infection in 
Asia and have proposed guidelines on course of future 
studies to be conducted in Asia.
The usage of antiretroviral therapy [ART] in this review 
[35.7%] was also a reflection of the reduced ART usage 
in Asian countries. The number of patients on ART was 
extremely variable; it was very difficult to extrapolate 
the prevalence rates of individual oral manifestations 
with ART in the review. There was a decrease in oral 
manifestations when ART usage was more than 50% in 
study sample. Immune reconstitution disease [IRD], a 
functionally partial reorganization of immune system, 
has been observed in individuals on HAART. Salivary 
gland enlargement, xerostomia, and oral warts also have 
been suggested to be consequences of IRD (43). Human 
papilloma virus [HPV] has been more commonly isola-
ted from the oral cavity of HIV positive patients as com-
pared to immunocompetent patients. Umadevi et al. (21) 
had conducted a longitudinal study in south Indian HIV 
patients on ART and no oral wart was documented in 
their study. Homosexual men typically have a prevalen-
ce of detectable HPV DNA ranging roughly from 80% to 
93% (38). In Asian studies predominantly heterosexual po-
pulation studies have been documented and the possibility 
of reduced frequency of orogenital contact [as documented 
in most of studies], could possibly explain the absence of 
oral warts (21). Studies need to be conducted measuring the 
stimulated and unstimulated salivary flow in a longitudinal 
cohort of HIV positive patients initially before HAART has 
begun and later at six months interval to accurately measure 
the impact of HAART on xerostomia. No reports of CMV 
sialadenitis were observed that could possibly be attributed 
to lack of resources to isolate the virus.
The most common oral manifestation expectedly was 
OC [with no predominant subtype prevalence]. The di-
fference in prevalence range of OC can be due to diffe-
rences in the prescribed medications, the stages of the 
disease or the route of transmission of the infection, and 
the longevity of HIV infection. Melanotic hyperpigmen-
tation was found with a greater frequency [22.8%] as 
compared to OHL [10.1%]. This can be attributed to a 
relatively greater usage of ART that tends to suppress 
OHL and promotes melanosis (27). 
An important aspect of this review was the absence of 
cases of Kaposi’s sarcoma in Asia, the malignant neopla-
sia most frequently associated with HIV /AIDS patients. 
The prevalence of Kaposi’s sarcoma has been found to 
be higher in Africa and developed world. Shiboski et 
al. (44) had recently postulated that, though oral squa-
mous cell carcinoma [SQCC] has not yet been shown 
to be associated with HIV ⁄ AIDS in studies, in the era 
of HAART, patients with HIV disease would live longer 
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and would be more likely to have carcinoma. Factors 
like greater availability of HAART, high prevalence of 
oral HPV infection and association of higher usage of to-
bacco either in smokeless or smoking may combine for a 
greater risk of developing oral SQCC in Asian countries 
(45). A recent review of malignancies of Head and neck 
region revealed 14 cases of oral SQCC outside Asia and 
also concluded that the HIV-associated carcinoma would 
occur at a relatively younger age group (45). NHL is re-
cognized as an AIDS defining condition in HIV-infected 
individuals and is included among the oral lesions asso-
ciated with HIV infection. The prevalence of NHL was 
found to be rare in Asia. Nevertheless, the authors pos-
tulate that oral malignancies, especially tobacco related, 
are likely to be documented more frequently in Asia as 
due to greater usage of ART in future there would be a 
likelihood of longer life span for HIV patients and thus 
these immunocompromised patients would be more ex-
posed to initiating oncogenic factors.
Asia accounts for one in six HIV-positive tuberculosis 
[TB] cases worldwide. Seven Asian countries are pre-
sent among the world’s 41 high HIV/TB burden coun-
tries: Cambodia, China, India, Indonesia, Myanmar, 
Thailand and Vietnam. Interestingly the prevalence of 
oral TB lesions in all the studies was extremely rare. 
There could be a possibility of misdiagnosis of TB ulcer 
as ulcer of NOS which may be attributed to lack of re-
sources in Asian countries. An early diagnosis and hence 
early management can help in the better quality of life 
to these patients.  
High rates of failure to follow-up the HIV patients dis-
courage the researchers to conduct longitudinal studies 
in Asian countries. The main constraint for future longi-
tudinal studies is lack of resources. A concerted effort by 
the health care workers in conjunction with the govern-
ment is required to improve antiretroviral therapy allo-
cation to patients to ensure an early management of HIV. 
According to recent UNAIDS report there is currently a 
deficit of 3.2 billion $ for the funding for achievement 
of 2015 target. The only way to breach trajectory of HIV 
is through increased domestic funding. This can occur 
only if a greater and consistent awareness about the HIV 
and its lethal complications are done in social media, 
print and electronic advertisement. Eradication of HIV 
can be done only through a multifaceted coordinated 
system where every speciality of health care should be 
involved actively and make things transpire instead of 
anticipating for HIV to get subjugated by a HIV vaccine 
cure or the government of respective countries accom-
plishing radical procedures.
There were 350000 new HIV infections in Asia and 
more than 90% of the new HIV infections are accounted 
by twelve countries in Asia-pacific region namely Chi-
na, India, Thailand, Pakistan, Indonesia, Cambodia, Ma-
laysia, Nepal, Myanmar, Philippines, Vietnam and Pa-
pua New Guinea. New HIV infections are concentrated 
among people who inject drugs, men who have sex with 
men and transgender people. Greater efforts should be 
done to safeguard HIV-related human rights, for people 
living with HIV and to ensure better availability to anti- 
HIV medications. A better access to oral health care is 
of utmost importance to these patients as there in neither 
cure nor a vaccine yet for HIV patients. However, long 
term progress would occur only if HIV features promi-
nently in countries’ future development agendas.
The biggest hindrance in providing adequate dental and 
medical health care other than the financial reasons is 
the societal stigma associated with HIV. In Indonesia, 
Malaysia, India and other Asian countries homosexual 
men face a twofold burden of HIV infection as well as 
homosexuality, thus constraining the HIV patient tota-
lly inaccessible and victimized. Therefore a necessity 
for a strong establishment or group that concentrates on 
management and counselling of homosexual HIV posi-
tive patient exclusively in Asian countries is required. 
The elimination of stigma, discrimination and injus-
tice against people affected by HIV in Asian countries 
though remains a perennial challenging task. A simple 
inexpensive dental health care with the medical set-up 
should also be integrated to cater to this unique group of 
the patients. Efforts should be made to ensure that HIV 
infected patient’s oral cavity is screened at every regular 
medical check-up visit. This requires amalgamation of 
partnership between medical personnel monitoring the 
HIV infection and dentist (46).
The systematic review conducted on oral manifestations 
do has some limitations. The computed prevalence of 
individual oral manifestations is not an exact indication 
as the clinical heterogeneity in race, habits, level of im-
munosuppression and gender prevalence in each study 
can make the comparison of studies very difficult. The 
ethnic diversities among the Asian population can create 
a variance of clinical presentation and there is a possi-
bility of inter-examiner variability also. Moreover the 
different medications of ART do have some variations 
on the immunity thus influencing the oral cavity. The ab-
solute CD4 counts were not considered by the authors as 
the data was not universal and standardized in respecti-
ve countries. The effect of the systemic medication also 
plays a role in the variations of the oral manifestations.
The formulation of an oral lesion index in the future 
would be an exciting and major breakthrough in the 
field of oral epidemiology in HIV/AIDS (31,47). Howe-
ver for the oral lesion index a combined prevalence of 
the oral manifestations in a given region is required and 
thus authors have conducted the review for the initial 
progress for the formulation of an oral lesion index. The 
authors suggest that the data derived in this review can 
subsequently be utilized in ensuing research studies fur-
ther to create a record for further help in analysis of oral 
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manifestations and the predictability of immune status 
from oral manifestations.
The research on oral manifestations in Asia has to upgra-
de to more interventional and therapeutic studies rather 
than the contemporary cross- sectional epidemiological 
descriptive studies. The only predicament for ensuing 
stage of research is “If not now, then when”? The au-
thors have given suggestions and future directions for 
the implementation of clinical research of oral manifes-
tations in HIV patients.
1. The quantity of conducted studies on oral manifes-
tations from Asia is sufficient but there is unequal dis-
tribution with most of studies in India and Thailand. 
Moreover, the data on oral manifestations in HIV/AIDS 
infected population is limited from Middle East coun-
tries, China and Japan. Research studies need to be con-
ducted in these regions.
2. A formulation of oral lesion index was suggested to 
predict HIV in resource poor countries with no access 
to CD4 count or viral load. Correlations between oral 
manifestations in HIV and absolute CD4 counts have 
been conducted in Asian countries but there is no clarity 
in data collection [eg. time duration, frequency, mono-
therapy or multidrug therapy and uniformity].  However 
rigorous research methodologies with emphasis on HIV 
Viral load and CD4/CD8 ratio need to be done. So far, 
only one study in Asia has correlated oral manifestations 
of HIV with viral load (31).
3. The guidelines by Shiboski et al. (44) in 2009 should 
be adopted in future studies as compared to EEC clea-
ringhouse [1993].
4. A centralized research authority needs to be instituted 
in each subregion of Asia [like south Asia, Middle East 
Asia, Southeast Asia etc.] for conducting research espe-
cially on clinical trials for management or oral lesions 
and thus making it more organized and treatment-cen-
tric. This would serve a dual purpose of saving resources 
as well as prevention of duplication of same study.
5. Studies need to be longitudinal and multicentric to 
exactly ascertain the prevalence of individual oral ma-
nifestations. Focus should also be on microbiological 
aspects of the studies like detection of strains of candida 
species as they are being conducted in developed nations 
(43). However, recently few studies in Asia have measu-
red the stimulated and unstimulated salivary flow (48).
6. Two examiners should preferably do the intraoral exa-
mination with blinding of HIV status to exactly ascer-
tain the prevalence of individual oral manifestation as a 
single examiner might be influenced by HIV status and 
there is always a risk of bias for over diagnosis of HIV 
related lesions especially OHL.
References
1. Arendorf T, Holmes H. Oral manifestations associated with human 
immunodeficiency virus (HIV) infection in developing countries – are 
there differences from developed countries? Oral Dis. 2000;6:133-5.
2. Sroussi HY, Villines D,Epstein J, Alves MC, Alves ME. Oral lesions 
in HIV positive dental patient - one more argument for tobacco cessa-
tion. Oral Dis. 2007;13:324-8.
3. Ranganathan K, Hemalatha R. Oral lesions in HIV in developing 
countries: An overview. Adv Dent Res. 2006;19:63-8.
4. Anil S, Challacombe SJ. Oral Lesions of HIV and AIDS in Asia: an 
overview. Oral Dis. 1997;3:S36-40.
5. Nittayananta W, Jealae S, Chungpanich S .Oral lesions in Thai hete-
rosexual AIDS patient. Br Dent J. 1997;182:219-21.
6. Nittayananta W, Chungpanich S. Oral lesions in a group of Thai 
people with AIDS. Oral Dis. 1997;3:S41-5.
7. Jing W, Ismail R. Mucocutaneous manifestations of HIV infection: 
a retrospective analysis of 145 cases in a Chinese population in Malay-
sia. Int J Dermatol. 1999;38:457-63.
8. Tsang PCS, Samaranayake LP. Oral manifestations of HIV infec-
tion in a group of predominantly ethnic Chinese. J Oral Pathol Med. 
1999;28:122-7.
9. Ranganathan K, Reddy BV, Kumarasamy N, Solomon S, Viswana-
nathan R, Johnson NW. Oral lesions and conditions associated with 
human immunodeficiency virus infection in 300 south Indian patients. 
Oral Dis. 2000;6:152-7.
10.Shimizu S, Chen KR, Tagami H, Hanabusa H. Mucocutaneous 
manifestations in Japanese HIV-positive hemophiliacs. Dermatology. 
2000;201:321-5.
11. Khongkunthian P, Grote M, Isaratan W, Piyaworawong S, Reichart 
PA. Oral manifestations in HIV positive adults from northern Thai-
land. J Oral Pathol Med. 2001;30:220-3.
12. Lim AA, Leo YS, Lee CC, Robinson AN. Oral manifestations of 
human immunodeficiency virus (HIV)-infected patients in Singapore. 
Ann Acad Med Singapore. 2001;30:600-6.
13. Nittayananta W, Chanowanna N, Sripatanakul S, Winn T. Risk 
factors associated with oral lesions in HIV Infected heterosexual 
people and intravenous drug users in Thailand. J Oral Pathol Med. 
2001;30:224-30.
14. Bendick C, Scheifele C, Reichart PA. Oral manifestations in 
101 Cambodian patients with HIV and AIDS. J Oral Pathol Med. 
2002;31:1-4.
15. Kerdpon D, Pongsiriwet S, Pangsomboon K, Iamaroon A, Kam-
poo K, Sretrirutchai S, et al. Oral manifestations of HIV infection in 
relation to clinical and CD4 immunological status in northern and 
southern Thai patients. Oral Dis. 2004;10:138-44.
16. Ranganathan K, Umadevi M, Saraswathi TR, Kumarasamy N, So-
lomon S, Johnson NW. Oral lesions and conditions associated with hu-
man immunodeficiency virus infection in 1000 south Indian patients. 
Ann Acad Med Singapore. 2004;33:S37-42.
17. Shobhana A, Guha SK, Neogi DK. Mucocutaneous manifestations 
of HIV infection. Indian J Dermatol Venereol Leprol. 2004;70:82-6.
18. Tzung TY, Yang CY, Chao SC, Lee JY. Cutaneous manifestations 
of human immunodeficiency virus infection in Taiwan. Kaohsiung J 
Med Sci. 2004;20:216-24.
19. Jensen TO, Tam VV, Mai NT, Ut do Q, Dat DD, Lien NT, et al. 
Oral and constitutional manifestations of HIV-infected hospital pa-
tients in Northern Vietnam. Southeast Asian J Trop Med Public Health. 
2005;36:1459-68.
20. Sharma G, Pai KM, Suhas S, Ramapuram JT, Doshi D, Anup N. 
Oral manifestations in HIV/AIDS infected potients from south India. 
Oral Dis. 2006;12:537-42.
21. Umadevi KM, Ranganathan K, Pavithra S,Hemalatha R, Sa-
raswathi TR, Kumarasamy N, et al. Oral lesions with HIV disease with 
and without highly active antiretroviral therapy in southern India. J 
Oral Pathol Med. 2007;36:136-41.
22. Kakabadze T,Rukhadze N,Mshvidobadze K, Lorntadze M, Kande-
laki G. Oral lesions in HIV-positive patients in Georgia. Georgian Med 
News. 2008;165:60-5.
23. Sharma G, Pai KM, Suhas S, Ramapuram JT, Nagpal A. Oral ma-
nifestations as predictors of immune suppression in a HIV-/AIDS- in-
fected population in south India. Clin Oral Invest. 2009;13:141-8.
24. Sud N, Shanker V, Sharma A, Sharma NL, Gupta M. Mucocu-
taneous manifestations in 150 HIV-infected Indian patients and 
J Clin Exp Dent. 2015;7(3):e419-27.                                                                                                                                                                   Oral manifestations of HIV/AIDS in Asia
e427
their relationship with CD4 lymphocyte counts. Int J STD AIDS. 
2009;20:771-4.
25. Davoodi P, Hamian M, Nourbaksh R, Ahmadi Motamayel F. Oral 
manifestations related to CD4 lymphocyte count in HIV-positive pa-
tients. J Dent Res Dent Clin Dent prospect. 2010;4:115-9.
26. Sen S, Mandal S, Bhattacharya S, Halder S, Bhaumik P. Oral mani-
festations in Human immunodeficiency virus infected patients. Indian 
J Dermatol. 2010;55:116-8.
27. Nittayananta W, Talungchit S, Jaruratanasirikul S, Silpapojakul K, 
Chayakul P, Nilmanat A,et al . Effects of long term use of HAART 
on oral Health status of HIV- infected patients. J Oral Pathol Med. 
2010;39:397-406.
28. Nittayanata W, Chanowanna N, Winn T. Mode of HIV transmis-
sion associated with risk of oral lesions in HIV-infected subjects in 
Thailand. J Oral Pathol Med. 2010;39:195-200.
29. Bodhade AS, Ganvir SM, Hazarey VK. Oral manifestations 
of HIV infection and their correlation with CD4 count. J Oral Sci. 
2011;53:203-11.
30. Khatibi M, Moshari AA, Jahromi ZM, Ramezankhani A. Preva-
lence of Oral Mucosal lesions and related factors in 200 HIV+/AIDS 
Iranian patients. J Oral Pathol Med. 2011;40:659-64.
31. Gaurav S, Keerthilatha PM, Archna N. Prevalence of Oral Mani-
festations and their association with CD4/CD8 ratio and HIV viral load 
in South India. Int J Dent. 2011;964278:1-8.
32. Sontakke SA, Umarji HR, Karjodkar F. Comparison of oral mani-
festations with CD4 counts in HIV –infected patients. Indian J Dent 
Res. 2011;22:732-6.
33. Patil BA, Mubeen, Ganapathy KS. Correlation of Oral Mani-
festations with circulating CD4+ T Lymphocytes in Patients with 
HIV/AIDS in Indian Subpopulation. J Ind Acad Oral Med Radiol. 
2011;23:502-6.
34. Annapurna CS, Prince CN, Sivaraj S, Ali IM. Oral manifestations 
of HIV patients in South Indian population. J Pharm bioallied Sci. 
2012; 4: S364-8.
35. Chopra S, Arora U. Skin and Mucocutaneous Manifestations: Useful 
Clinical Predictors of HIV/AIDS. J Clin Diagn Res. 2012;6:1695-8.
36. Han J, Lun WH, Meng ZH, Huang K, Mao Y, Zhu W, et al. Mu-
cocutaneous manifestations of HIV infected patients in era of HAART 
in Guangxi Zhuang autonomous region, China. J Eur Acad Dermatol 
Venerol. 2013;27:376-82.
37. Perera M, Tsang PC, Samaranayake L, Lee MP, Li P. Prevalence of 
Oral Mucosal lesions in adults undergoing Highly active antiretroviral 
therapy in Hongkong. J Invest Clin Dent. 2012;3:208-14.
38. Rao UK, Ranganathan K, Kumarasamy N. Gender differences in 
Oral lesions among persons with HIV disease in southern India. J Oral 
Maxillofac Pathol. 2012; 16: 388-94.
39. Kiran K, Shetty S. Oral and periodontal manifestations among HIV 
population in southern India. Int J Bas Appl Med Sci. 2013;3:184-9.
40. Naidu GS, Thakur R, Singh AK, Rajbhandary S, Mishra RK, Sa-
gtani A. Oral lesions and immune status of HIV infected adults from 
eastern Nepal. J Clin Exp Dent. 2013;5:e1-7.
41. Pattrapornnan P, DeRouen TA. Associations of periodontitis and 
oral manifestations with CD4 counts in human immunodeficiency 
virus-pregnant women in Thailand. Oral Surg Oral Med Oral Pathol 
Oral Radiol. 2013;116:306-12.
42. Bakhshaee M, Sarvghad MR, Khazaeni K, Movahed R, Hoseinpour 
AM.HIV: An Epidemiologic study on Head and Neck Involvement in 
50 Patients. Iran J Otorhinolaryngol. 2014; 26 :97-104.
43.Navazesh M, Mulligan R, Pogoda J, Greenspan D, Alves M, Phelan 
J, et al . The effect of HAART on salivary microbiota in the Women’s 
Interagency HIV Study (WIHS). Oral Surg Oral Med Oral Pathol Oral 
Radiol Endod. 2005;100:701-8.
44. Shiboski CH, Patton LL, Webster-Cyriaque JY, Greenspan D, Tra-
bousli RS, Ghannoum M, et al. The oral HIV/AIDS research alliance: 
updated case definitions of oral disease endpoints. J Oral Pathol Med. 
2009;38:481-8.
45. Purgina B, Pantanowitz L, Seethala RR. A review of carcinomas 
arising in the head and neck region in HIV-positive patients. Patholog 
Res Int. 2011;569150:1-12.
46. Coogan MM, Greenspan J, Challacombe SJ. Oral lesions in infec-
tion with human immunodeficiency virus. Bull World health organ. 
2005;83:700-6.
47. Patton LL, Ranganathan K, Naidoo S, Bhayat A, Balasundaram S, 
Adeyemi O, et al. Oral lesions, HIV phenotypes, and management of 
HIV-related disease: workshop 4A. Adv Dent Res. 2011;23:112-6.
48.Pavithra S, Ranganathan K, Umadevi RK, Joshua E, Rooban T, 
Kumarasamy N. Impact of highly active retroviral therapy on sali-
vary flow in patients with human- immunodeficiency virus disease in 
southern India. J Oral Maxillofac Pathol. 2013;17:17-22.
